183 related articles for article (PubMed ID: 35018094)
1. Open-Label, Phase I, Pharmacokinetic Studies in Healthy Chinese Subjects to Evaluate the Bioequivalence and Food Effect of a Novel Formulation of Abiraterone Acetate Tablets.
Feng Z; Liu Y; Kuang Y; Yang S; Li J; Ye L; Huang J; Pei Q; Huang Y; Yang G
Drug Des Devel Ther; 2022; 16():3-12. PubMed ID: 35018094
[TBL] [Abstract][Full Text] [Related]
2. Bioequivalence, food effect and comparative pharmacokinetics of SUVN-1105, a novel granule formulation of abiraterone acetate, to Zytiga in healthy male subjects.
Nirogi R; Ravula J; Benade V; Goyal VK; Pandey SK; Dogiparti D; Jayarajan P; Kalaikadhiban I; Jetta S; Palacharla VRC
Cancer Chemother Pharmacol; 2024 Mar; 93(3):253-264. PubMed ID: 38157042
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and bioequivalence of generic and branded abiraterone acetate tablet: a single-dose, open-label, and replicate designed study in healthy Chinese male volunteers.
Wang C; Hu C; Gao D; Zhao Z; Chen X; Hu X; Gong S; Li L; Zhang L
Cancer Chemother Pharmacol; 2019 Mar; 83(3):509-517. PubMed ID: 30535959
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of reference-scaled average bioequivalence of two oral formulations of abiraterone acetate in healthy Chinese subjects
.
Li C; Ding Y; Yang D; Wang M; Hu Y; Zhang H; Zhu X; Chen G; Li X; Wu M; Liu J; Chen H; Liu C; Shen Z; Liu B
Int J Clin Pharmacol Ther; 2018 Nov; 56(11):562-570. PubMed ID: 30220293
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and Bioequivalence of Abiraterone Acetate Tablets in Healthy Chinese Volunteers: An Open, Randomized, Single-Dose, Three-Period, Three-Sequence Crossover Study.
Wu ZX; Wang CJ; Shi P; Liu YP; Li T; Sun FF; Fu Y; Gao XM; Ma YP; Cao Y
Drugs R D; 2023 Jun; 23(2):121-127. PubMed ID: 37012461
[TBL] [Abstract][Full Text] [Related]
6. Demonstrating Bioequivalence for Two Dose Strengths of Niraparib and Abiraterone Acetate Dual-Action Tablets Versus Single Agents: Utility of Clinical Study Data Supplemented with Modeling and Simulation.
Yu A; Hazra A; Jiao JJ; Hellemans P; Mitselos A; Tian H; Ruixo JJP; Haddish-Berhane N; Ouellet D; Russu A
Clin Pharmacokinet; 2024 Apr; 63(4):511-527. PubMed ID: 38436924
[TBL] [Abstract][Full Text] [Related]
7. Bioequivalence study of two perindopril tert-butylamine tablet formulations in healthy Chinese subjects under fasting and fed conditions: A randomized, open-label, single-dose, crossover trial.
Li Q; Hao Z; Yu Y; Tang Y
Biomed Pharmacother; 2021 Mar; 135():111221. PubMed ID: 33433351
[TBL] [Abstract][Full Text] [Related]
8. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
9. Comparison of a Novel Formulation of Abiraterone Acetate vs. the Originator Formulation in Healthy Male Subjects: Two Randomized, Open-Label, Crossover Studies.
Goldwater R; Hussaini A; Bosch B; Nemeth P
Clin Pharmacokinet; 2017 Jul; 56(7):803-813. PubMed ID: 28425029
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of oral cyanocobalamin formulated with sodium N-[8-(2-hydroxybenzoyl)amino]caprylate (SNAC): an open-label, randomized, single-dose, parallel-group study in healthy male subjects.
Castelli MC; Wong DF; Friedman K; Riley MG
Clin Ther; 2011 Jul; 33(7):934-45. PubMed ID: 21722960
[TBL] [Abstract][Full Text] [Related]
11. A prospective phase I multicentre randomized cross-over pharmacokinetic study to determine the effect of food on abiraterone pharmacokinetics.
Lubberman FJE; Benoist GE; Gerritsen W; Burger DM; Mehra N; Hamberg P; van Oort I; van Erp NP
Cancer Chemother Pharmacol; 2019 Dec; 84(6):1179-1185. PubMed ID: 31515667
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and Bioequivalence of 2 Olanzapine Orally Disintegrating Tablet Products in Healthy Chinese Subjects Under Fed and Fasting Conditions.
Fan L; Zhang L; Zheng H; Cheng J; Hu Y; Liu J; Fan H
Clin Pharmacol Drug Dev; 2020 Jul; 9(5):593-601. PubMed ID: 32413238
[TBL] [Abstract][Full Text] [Related]
13. Bioequivalence of 2 Aripiprazole Orally Disintegrating Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
Xiang J; Xu N; Wang X; Li S; Yu Q; Liang M; Nan F; Shu S; Yan R; Zhu Y; Liao L
Clin Pharmacol Drug Dev; 2021 Aug; 10(8):840-849. PubMed ID: 34105265
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and bioequivalence studies of fluvoxamine maleate tablets in healthy Chinese subjects.
She DP; He Y; Li MQ; Su L; Ren D; Huang XH; Zhang YH; Hu HT; Deng DC; Wu JL
Biomed Chromatogr; 2023 Jun; 37(6):e5613. PubMed ID: 36849133
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics, Bioequivalence and Safety Evaluation of Two Ticagrelor Tablets Under Fasting and Fed Conditions in Healthy Chinese Subjects.
Wang J; Zhang H; Wang R; Cai Y
Drug Des Devel Ther; 2021; 15():1181-1193. PubMed ID: 33758499
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, Bioequivalence and Safety of Cloperastine in Chinese Healthy Subjects Under Fasting and Postprandial Conditions.
Luo HY; Long HZ; Zhou ZW; Xu SG; Li FJ; Cheng Y; Wen DD; Deng P; Gao LC
Drugs R D; 2022 Dec; 22(4):311-320. PubMed ID: 36369609
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and Safety of Posaconazole Administered by Intravenous Solution and Oral Tablet in Healthy Chinese Subjects and Effect of Food on Tablet Bioavailability.
Li H; Wei Y; Zhang S; Xu L; Jiang J; Qiu Y; Mangin E; Zhao XM; Xie S
Clin Drug Investig; 2019 Nov; 39(11):1109-1116. PubMed ID: 31432392
[TBL] [Abstract][Full Text] [Related]
18. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study.
Li KY; Liang JP; Hu BQ; Qiu Y; Luo CH; Jiang Y; Lin XP; Yang N
Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325
[TBL] [Abstract][Full Text] [Related]
19. Bioequivalence and Pharmacokinetic Study of 2 Edoxaban Tablets in Healthy Chinese Subjects.
Liu L; Li X; Liu Y; Xu B; Li Y; Yuan F; Zhang P; Tu S; Hu W
Clin Pharmacol Drug Dev; 2022 Dec; 11(12):1440-1446. PubMed ID: 35950601
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and bioequivalence evaluation of acamprosate calcium tablets in healthy Chinese volunteers.
Luo Z; Shen Y; Liang M; Miao J; Mei Y; Wang Y; Qin Y
Eur J Pharm Sci; 2015 Nov; 79():67-72. PubMed ID: 26360834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
